Effect of licorice on the induction of phase II metabolizing enzymes and phase III transporters and its possible mechanism

Pharmazie

Volumn 69, Issue 12, 2014, Pages 894-897

  Gong, Hui ^a,b   Li, Huan De ^a,b   Yan, Miao ^a,b   Zhang, Bi Kui ^a,b   Jiang, Pei ^a,b   Fan, Xin Rong ^c   Deng, Yang ^a,b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLIZING ENZYME; GLUCURONOSYLTRANSFERASE 1A1; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE TRANSFERASE; GLYCYRRHIZA EXTRACT; MESSENGER RNA; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 2; TRANSCRIPTION FACTOR NRF2; CARRIER PROTEIN; ENZYME; MIXED FUNCTION OXIDASE; MULTIDRUG RESISTANCE PROTEIN; NFE2L2 PROTEIN, HUMAN; P-GLYCOPROTEIN 2; PLANT EXTRACT;

ARTICLE; CONTROLLED STUDY; DETOXIFICATION; DRUG EFFECT; DRUG INTOXICATION; GENE EXPRESSION; GLYCYRRHIZA; HEPG2 CELL LINE; HUMAN; HUMAN CELL; CELL LINE; DRUG EFFECTS; METABOLISM;

CARRIER PROTEINS; CELL LINE; ENZYMES; GLYCYRRHIZA; HUMANS; MIXED FUNCTION OXYGENASES; NF-E2-RELATED FACTOR 2; P-GLYCOPROTEINS; PLANT EXTRACTS;

EID: 84920785305     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2014.4615     Document Type: Article

References (23)

1. Chan K, Kan YW (1999) Nrf2 is essential for protection against acute pulmonary injury in mice. Proc Natl Acad Sci USA 96: 12731-12736.
2. Enomoto A, Itoh K, Nagayoshi E, Haruta J, Kimura T, O'Connor T, Harada T, Yamamoto M (2001) High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes. Toxicol Sci 59: 169-177.
3. Font A, Sanchez JM, Taron M, Martinez-Balibrea E, Sanchez JJ, Manzano JL, Margeli M, Richardet M, Barnadas A, Abad A, Rosell R (2003) Weekly regimen of irinotecan/docetaxel in previously treated non-small cell lung cancer patients and correlation with uridine diphosphate glucuronosyltransferase1A1 (UGT1A1) polymorphism. Invest New Drugs 21: 435-443.
4. Gupta E, Lestingi TM, Mick R, Ramirez J, Vokes EE, Ratain MJ (1994) Metabolic fate of irinotecan in humans: correlation of glucuronidation with diarrhea. Cancer Res 54: 3723-3725.
5. Huang TC, Chung YL, Wu ML, Chuang SM (2011) Cinnamaldehyde enhances Nrf2 nuclear translocation to upregulate phase II detoxifying enzyme expression in HepG2 cells. J Agric Food Chem 59: 5164-5171.
6. Ishii Y, Nurrochmad A, Yamada H (2010) Modulation of UDPglucuronosyltransferase activity by endogenous compounds. Drug Metab Pharmacokinet 25:134-148.
7. Jana S, Mandlekar S (2009) Role of phase II drug metabolizing enzymes in cancer chemoprevention. Current Drug Metabol 10: 595-616.
8. Keum YS (2012) Regulation of Nrf2-mediated phase II detoxification and anti-oxidant genes. Biomol Ther (Seoul) 20: 144-151.
9. Klaassen CD, Slitt AL (2005) Regulation of hepatic transporters by xenobiotic receptors. Current Drug Metabol 6: 309-328.
10. Kohle C, Bock KW (2007) Coordinate regulation of Phase I and II xenobiotic metabolisms by the Ah receptor and Nrf2. Biochem Pharmacol 73: 1853-1862.
11. Konig J, Nies AT, Cui Y, Leier I, Keppler D (1999) Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance. Biochim Biophys Acta 1461: 377-394.
12. Lu SC (2013) Glutathione synthesis. Biochim Biophys Acta 1830: 3143-3153.
13. Ma Q, He X (2012) Molecular basis of electrophilic and oxidative defense: promises and perils of Nrf2. Pharmacol Rev 64: 1055-1081.
14. Maher JM, Dieter MZ, Aleksunes LM, Slitt AL, Guo G, Tanaka Y, Scheffer GL, Chan JY, Manautou JE, Chen Y, Dalton TP, Yamamoto M, Klaassen CD (2007) Oxidative and electrophilic stress induces multidrug resistance-associated protein transporters via the nuclear factor-E2-related factor-2 transcriptional pathway. Hepatology 46: 1597-1610.
15. Mandlekar S, Hong JL, Kong AN (2006) Modulation of metabolic enzymes by dietary phytochemicals: a reviewof mechanisms underlying beneficial versus unfavorable effects. Current Drug Metabol 7: 661-675.
16. Niture SK, Kaspar JW, Shen J, Jaiswal AK (2010) Nrf2 signaling and cell survival. Toxicol Appl Pharmacol 244: 37-42.
17. Qiao X, Ye M, Xiang C, Bo T, Yang WZ, Liu CF, Miao WJ, Guo DA (2012) Metabolic regulatory effects of licorice: a bile acid metabonomic study by liquid chromatography coupled with tandem mass spectrometry. Steroids 77: 745-755.
18. Shen G, Kong, AN (2009) Nrf2 plays an important role in coordinated regulation of Phase II drug metabolism enzymes and Phase III drug transporters. Biopharm Drug Dispos 30: 345-355.
19. TanQY(2012) Effects of C-18 epimers of glycyrrhizic acid and their hydrolysis products on phase II detoxification enzymes and its mechanism research [D]. Central South University, China.
20. Vollrath V, Wielandt AM, Iruretagoyena M, Chianale J (2006) Role of Nrf2 in the.regulation of the Mrp2 (ABCC2) gene. Biochem J 395: 599-609.
21. Wang X, Zhang H, Chen L, Shan L, Fan G, Gao X (2013) Liquorice, a unique "guide drug" of traditional Chinese medicine: a review of its role in drug interactions. J Ethnopharmacol 150: 781-790.
22. Wu TY, Khor TO, Saw CL, Loh SC, Chen AI, Lim SS, Park JH, Cai L, Kong AN (2011) Anti-inflammatory/Anti-oxidative stress activities and differential regulation of Nrf2-mediated genes by non-polar fractions of tea Chrysanthemum zawadskii and licorice Glycyrrhiza uralensis. AAPS J 13: 1-13.
23. Xing PP, Wu WH, Du P, Han FM, Chen Y (2011) Effects of brucine combined with glycyrrhetinic acid or liquiritin on rat hepatic cytochrome P450 activities in vivo. Yao Xue Xue Bao 46: 573-580.